Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
Authors
Keywords
-
Journal
BRAIN
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-10-20
DOI
10.1093/brain/awab404
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions
- (2021) Emma L. van der Ende et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
- (2021) John W Day et al. LANCET NEUROLOGY
- Aducanumab: What about the Patient?
- (2021) Ronald C. Petersen ANNALS OF NEUROLOGY
- Controversy and Progress in Alzheimer’s Disease — FDA Approval of Aducanumab
- (2021) Gil D. Rabinovici NEW ENGLAND JOURNAL OF MEDICINE
- Approval of Aducanumab for Alzheimer Disease—the FDA’s Perspective
- (2021) Billy Dunn et al. JAMA Internal Medicine
- Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS
- (2020) Howard J. Rosen et al. Alzheimers & Dementia
- The characterisation of subjective cognitive decline
- (2020) Frank Jessen et al. LANCET NEUROLOGY
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers
- (2020) Gabriella Le Blanc et al. ANNALS OF NEUROLOGY
- A proposal for new diagnostic criteria for ALS
- (2020) Jeremy M. Shefner et al. CLINICAL NEUROPHYSIOLOGY
- A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)
- (2020) Mercedeh Ghadessi et al. Orphanet Journal of Rare Diseases
- Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies
- (2020) Wolfgang Singer et al. ANNALS OF NEUROLOGY
- Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
- (2020) Timothy Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cerebrospinal Fluid Levels of Prodynorphin‐Derived Peptides Are Decreased in Huntington's Disease
- (2020) MHD Rami Al Shweiki et al. MOVEMENT DISORDERS
- Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
- (2020) Valter Niemela et al. MOVEMENT DISORDERS
- Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease
- (2020) Filipe B. Rodrigues et al. Science Translational Medicine
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Defining pre-symptomatic amyotrophic lateral sclerosis
- (2019) Michael Benatar et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
- (2019) Richard M. Tsai et al. Alzheimers Research & Therapy
- Prodromal Parkinson's Disease: The Decade Past, the Decade to Come
- (2019) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study
- (2019) Henri J M M Mutsaerts et al. BRAIN
- Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
- (2019) Ronald B Postuma et al. BRAIN
- Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study
- (2019) Seyed-Mohammad Fereshtehnejad et al. BRAIN
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurofilament as a potential biomarker for spinal muscular atrophy
- (2019) Basil T. Darras et al. Annals of Clinical and Translational Neurology
- Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers
- (2019) Qin Chen et al. JOURNAL OF NEUROIMAGING
- Update of the MDS research criteria for prodromal Parkinson's disease
- (2019) Sebastian Heinzel et al. MOVEMENT DISORDERS
- Parkinson disease genetics: too early to predict progression?
- (2019) Gregor Kuhlenbäumer et al. Nature Reviews Neurology
- Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
- (2019) Darryl C. De Vivo et al. NEUROMUSCULAR DISORDERS
- Neurofilaments in pre-symptomatic ALS and the impact of genotype
- (2019) Michael Benatar et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology
- (2019) Bradley Boeve et al. Alzheimers & Dementia
- Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration
- (2019) Nicholas T. Olney et al. Alzheimers & Dementia
- Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers
- (2019) Qin Chen et al. NEUROBIOLOGY OF AGING
- P.214Presymptomatic spinal muscular atrophy: reality or myth?
- (2019) L. Lowes et al. NEUROMUSCULAR DISORDERS
- Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
- (2019) Tamara Dangouloff et al. Therapeutics and Clinical Risk Management
- Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
- (2019) Katrina M Moore et al. LANCET NEUROLOGY
- Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
- (2019) Emma L van der Ende et al. LANCET NEUROLOGY
- Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study
- (2019) Qin Chen et al. NEUROBIOLOGY OF AGING
- Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS)
- (2018) Sandra Weintraub et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Neurofilament light: A candidate biomarker of pre-symptomatic ALS and phenoconversion
- (2018) Michael Benatar et al. ANNALS OF NEUROLOGY
- In vivo18F-AV-1451 tau PET signal inMAPTmutation carriers varies by expected tau isoforms
- (2018) David T. Jones et al. NEUROLOGY
- Subjective cognitive decline and risk of MCI
- (2018) Argonde C. van Harten et al. NEUROLOGY
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials
- (2018) Jessica Lim et al. Therapeutic Innovation & Regulatory Science
- How early can we diagnose Alzheimer disease (and is it sufficient)?
- (2018) Ronald C. Petersen NEUROLOGY
- Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease
- (2018) Lauren M. Byrne et al. Science Translational Medicine
- Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials
- (2018) Adam M Staffaroni et al. BRAIN
- Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
- (2017) Lauren M Byrne et al. LANCET NEUROLOGY
- Practice guideline update summary: Mild cognitive impairment
- (2017) Ronald C. Petersen et al. NEUROLOGY
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- ECAS A-B-C: alternate forms of the Edinburgh Cognitive and Behavioural ALS Screen
- (2017) Christopher J. Crockford et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
- (2017) Michael J. Strong et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal Cohort
- (2017) Danna Jennings et al. JAMA Neurology
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Tau or neurofilament light—Which is the more suitable biomarker for Huntington’s disease?
- (2017) Valter Niemelä et al. PLoS One
- Molecular genetics of early-onset Alzheimer's disease revisited
- (2016) Rita Cacace et al. Alzheimers & Dementia
- Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment
- (2016) Zahinoor Ismail et al. Alzheimers & Dementia
- Presymptomatic ALS genetic counseling and testing
- (2016) Michael Benatar et al. NEUROLOGY
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI)
- (2016) Marwa Elamin et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS)
- (2016) et al. JAMA Neurology
- Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease
- (2015) Jong-Min Lee et al. CELL
- Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients
- (2015) Edward J. Wild et al. JOURNAL OF CLINICAL INVESTIGATION
- Reliable Change on Neuropsychological Tests in the Uniform Data Set
- (2015) Brandon E. Gavett et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Frontotemporal dementia
- (2015) Jee Bang et al. LANCET
- Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
- (2015) Jonathan D Rohrer et al. LANCET NEUROLOGY
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression
- (2015) Amber L. Southwell et al. Scientific Reports
- Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
- (2015) Kristin Harkins et al. Alzheimers Research & Therapy
- Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders
- (2015) Elaine Niven et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- When Does an Illness Begin: Genetic Discrimination and Disease Manifestation
- (2015) Anya E. R. Prince et al. JOURNAL OF LAW MEDICINE & ETHICS
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
- (2014) Frank Jessen et al. Alzheimers & Dementia
- Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study
- (2014) Jane S Paulsen et al. LANCET NEUROLOGY
- Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
- (2014) Daniela Berg et al. MOVEMENT DISORDERS
- The prevalence of Parkinson's disease: A systematic review and meta-analysis
- (2014) Tamara Pringsheim et al. MOVEMENT DISORDERS
- Magnetic resonance imaging striatal volumes: A biomarker for clinical trials in Huntington's disease
- (2014) Elizabeth H. Aylward MOVEMENT DISORDERS
- Huntington disease: natural history, biomarkers and prospects for therapeutics
- (2014) Christopher A. Ross et al. Nature Reviews Neurology
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
- (2013) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Use of historical control data for assessing treatment effects in clinical trials
- (2013) Kert Viele et al. PHARMACEUTICAL STATISTICS
- Screening for cognition and behaviour changes in ALS
- (2013) Sharon Abrahams et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Evidence-Based Indicators of Neuropsychological Change in the Individual Patient: Relevant Concepts and Methods
- (2012) K. Duff ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- The PRIPS study: screening battery for subjects at risk for Parkinson's disease
- (2012) D. Berg et al. EUROPEAN JOURNAL OF NEUROLOGY
- Advances in understanding the molecular basis of frontotemporal dementia
- (2012) Rosa Rademakers et al. Nature Reviews Neurology
- Presymptomatic studies in ALS: Rationale, challenges, and approach
- (2012) M. Benatar et al. NEUROLOGY
- Electrophysiological and motor function scale association in a pre-symptomatic infant with spinal muscular atrophy type I
- (2012) Richard S. Finkel NEUROMUSCULAR DISORDERS
- Pre-MCI and MCI: Neuropsychological, Clinical, and Imaging Features and Progression Rates
- (2011) Ranjan Duara et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Indexing disease progression at study entry with individuals at-risk for Huntington disease
- (2011) Ying Zhang et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Striatal Volume Contributes to the Prediction of Onset of Huntington Disease in Incident Cases
- (2011) Elizabeth H. Aylward et al. BIOLOGICAL PSYCHIATRY
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis
- (2011) Joanna H Fanos et al. GENETICS IN MEDICINE
- Classification of primary progressive aphasia and its variants
- (2011) M. L. Gorno-Tempini et al. NEUROLOGY
- Mild Cognitive Impairment
- (2011) Ronald C. Petersen NEW ENGLAND JOURNAL OF MEDICINE
- Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson’s disease
- (2010) R. Constantinescu et al. ACTA NEUROLOGICA SCANDINAVICA
- The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis
- (2010) Joost Raaphorst et al. Amyotrophic Lateral Sclerosis
- Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™)
- (2010) Susan C. Woolley et al. Amyotrophic Lateral Sclerosis
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
- (2010) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer's disease and behavioral variant frontotemporal dementia
- (2010) Katherine L. Possin et al. NEUROPSYCHOLOGIA
- CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches
- (2009) Douglas R. Langbehn et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis
- (2009) Michael J. Strong et al. Amyotrophic Lateral Sclerosis
- Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
- (2009) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study
- (2009) Kevin M. Biglan et al. MOVEMENT DISORDERS
- Medical records documentation of constipation preceding Parkinson disease: A case-control study
- (2009) R. Savica et al. NEUROLOGY
- Detection of Huntington's disease decades before diagnosis: the Predict-HD study
- (2007) J S Paulsen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started